SEC Form 4 · accession 0001128732-16-000018
Sunshine Biopharma Inc. · SBFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve N. Slilaty
Officer — Chief Executive Officer · Director
Period of report
Apr 12, 2016
Accepted (ET)
Apr 26, 2016 · 8:49 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001402328
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 12, 2016 | P | 253,082 | $0.1976 | A | 30,570,776 | I | Owned by Advanomics Corporation, an entity controlled by Reporting Person. |
| Common Stock | Apr 22, 2016 | A | 12,000,000 | $0.007 | A | 12,384,373 | D |
Table II — derivative securities
No Table II lines on this filing.